SZM679
Product Specifications
Target
RIP kinase
Related Pathways
Apoptosis, NF-κB
Bioactivity
SZM679 is an orally active, selective RIPK1 inhibitor displaying potent affinity with a dissociation constant (Kd) of 8.6 nM for RIPK1, while exhibiting minimal activity towards RIPK3, with a Kd of >5000 nM. It effectively counteracts tumor necrosis factor-induced systemic inflammation, reduces Tau hyperphosphorylation, diminishes neuroinflammation, and lowers RIPK1 phosphorylation in the hippocampus and cortex. SZM679 is utilized in Alzheimer's disease (AD) research [1].
Smiles
C1C(CC1=O)C(=O)NC2=NC3=CC(=C(C=C3S2)OC4=CC(=C(C=C4)F)NC(=O)CC5=CC(=CC=C5)OC(F)(F)F)F
Molecular Formula
C27H18F5N3O5S
Molecular Weight
591.51
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
A00128-4-HRP 100 µg/Vial
Anti-TRPV1 Antibody Picoband®, HRP Conjugate
Sign In for Pricing
View Details 
bs-14274R-APC-Cy7 100 µL
DENND5A Polyclonal Antibody, APC-Cy7 Conjugated
Sign In for Pricing
View Details